Overall rank by patents
#38,176
of 49,997 tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H01M (Processes OR Means, e.g. Batteries, FOR THE Direct Conversion OF Chemical Energy Into Electrical Energy).
The verdict
According to USPTO PatentsView, Venture ranks #38,176 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 8 technology areas.
USPTO PatentsView assignee plate
Corpus R38176 · US Corporation #38,176 · 7 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Vaxil Biotherapeutics Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Venture Lending &… · this assignee
35 score
3D Lighting… · lowest
7 score
What this shows Venture's Innovation Score is 35.1/100 (top 50% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Venture Lending & Leasing Viii, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 42.9% of grants classified under H01M (Processes OR Means, e.g. Batteries, FOR THE Direct Conversion OF Chemical Energy Into Electrical Energy). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2024. By volume, Venture sits between Vaxil Biotherapeutics Ltd. and Verdant Bioproducts Limited.
Venture Lending & Leasing Viii, Inc. shows 1 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Vaxil Biotherapeutics Ltd.
7 patents
Vdopia Inc.
7 patents
Vekoma Rides Engineering B.V.
7 patents
Venmill Industries, Inc.
7 patents
Ventus Networks LLC
7 patents
Veoneer US Safety Systems, LLC
7 patents
VERA
7 patents
Verdant Bioproducts Limited
7 patents
Venture Lending & Leasing Viii, Inc.
7 patents
What this shows Venture holds 7 patents at rank #38,133, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #38,133 in granted patent volume.
Other assignees with the most granted patents in Venture's primary technology class.
Venture's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 Top 50% higher than 50% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 28.6% |
| 2016 | 2 | 28.6% |
| 2024 | 1 | 14.3% |
| 2025partial year | 2 | 28.6% |
Top 8 of 8 technology areas
Overall rank by patents
#38,176
of 49,997 tracked assignees
35.1 out of 100
What to do with this data
Venture Lending & Leasing Viii, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.